Sudoscan: Analysis of the Sweat Response According to the Pathology in Neurologic Patients
Study Details
Study Description
Brief Summary
Cardiovascular autonomic neuropathy (CAN) has been shown to be an important risk factor for cardiac diseases, particularly in diabetes.
CAN may be investigated by a battery of laboratory cardiovascular autonomic reflex tests(initially described by Ewing).
First screening for CAN (as proposed in diabetic patients) can be performed by assessing heart rate (HR) response to deep breathing, blood pressure (BP) and HR response to a 5 minutes stand test
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Sweat glands are innervated by thin and un myelinated sympathetic C-fibers that can be impaired in neuropathies,especially length-dependent ones. Sweating dysfunction has been shown in several neurological peripheral disorders and it has been suggested that sweating function should be included among the diagnostic tests for the early detection of autonomic neuropathies. Several methods have been developed, but the lack of easy and quick tests to diagnose sweating dysfunction has restricted widespread use in clinical practice. Measurement of electrochemical skin conductance (ESC) using Sudoscan® is a new method for quick, non-invasive and quantitative assessment of sweating. This technique has demonstrated its usefulness in detecting autonomic and small fiber neuropathy, especially in diabetic patients.The aim of this study was to evaluate the performance of the laboratory battery of CV tests and of sweating dysfunction by Sudoscan®, alone or in combination, to differentiate MSA-P from PD. Among the CV tests, the present study particularly looked at those tests already recommended as screening bedside tests in diabetic patients (HR variations with deep breathing and BP variations during stand test) ; these tests are rapid and easy to perform. HR variations with deep breathing depend on parasympathetic tone and BP variations depend on vasomotor sympathetic response.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| MSA-P Patients with multiple systeme atrophy (MSA) with predominant parkinsonism (MSA-P) had evaluation of cardiovascular function and sweating function |
Procedure: sweating function
Sweating dysfunction by Sudoscan
Other Names:
Procedure: Cardiovascular function
Cardiovascular (CV) tests
|
| PD patients Parkinson's disease (PD) patients had evaluation of cardiovascular function and sweating function |
Procedure: sweating function
Sweating dysfunction by Sudoscan
Other Names:
Procedure: Cardiovascular function
Cardiovascular (CV) tests
|
Outcome Measures
Primary Outcome Measures
- Sweating autonomic test [baseline]
Evaluate the performance of the laboratory battery of CV tests and of sweating dysfunction to differentiate MSA-P from PD
Eligibility Criteria
Criteria
Inclusion Criteria:
- Patients with MSA-P or PD
Exclusion Criteria:
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University Hospital, Toulouse
Investigators
- Principal Investigator: Anne Pavy-Le Traon, MD, University Hospital, Toulouse
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- RC31/15/7550